Search

Showing 71 - 80 of 445 results.

Key Features

Two Amplatzer™ ASD Closure Devices for Optimizing Patient Care Abbott offers two devices for percutaneous, transcatheter ASD closure.
Patients who benefit

The importance of treating patients with Atrial Septal Defects Patients diagnosed with an ASD, who are indicated for closure with an Amplatzer™ Septal Occluder, exhibit both6: Echocardiographic
Overview

TREATMENT RANGE 4 MM TO 40 MM No other ASD closure device on the market today can match ASO’s wide range of device sizes.
Clinical Data

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PDA closure CAP=continued access protocol, IDE=investigational device exemption.
Recommendations

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PDA closure EARLY TRANSCATHETER INTERVENTION CAN IMPROVE OUTCOMES4 Early PDA cl
Diagnosis & Treatment

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PDA closure Echocardiography and/or angiography can differentiate between patent
Patients who benefit

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PDA closure PATENT DUCTUS ARTERIOSUS (PDA) CLOSURE IN INFANTS Narrowing of the du
Overview

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PDA closure If PDA is left untreated, the mortality rate is 20% by age 20 years,
Amplatzer™ Duct Occluder

SWITCH TO THE REFERRAL VIEW For more information specific to neonatology regarding PDA closure AMPLATZER™ DUCT OCCLUDER: FOR LARGE PDA CLOSURE
Amplatzer™ Duct Occluder II

SWITCH TO THE REFERRAL VIEW For more information specific to neonatology regarding PDA closure AMPLATZER™ DUCT OCCLUDER II: VERSATILITY TO CONFORM TO A VARIETY OF PDAs